Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Sernova Corp T.SVA

Alternate Symbol(s):  SEOVF

Sernova Corp. is a Canada-based clinical-stage biotechnology company, which is developing therapeutic cell technologies for chronic diseases, including insulin-dependent diabetes, thyroid disease, and blood disorders that include hemophilia A. The Company is focused on developing a functional cure for insulin-dependent diabetes with its therapeutic cell technology, the Cell Pouch System, a novel implantable and scalable medical device with immune protected therapeutic cells. The Cell Pouch is a scalable, implantable medical device. The Cell Pouch is designed to create a vascularized organ-like environment for the transplantation and engraftment of therapeutic cells. Its regenerative medicine therapeutic approach is to provide cell therapies where the cells, transplanted within an organ-like vascularized implantable device, the Cell Pouch, generates proteins, hormones or factors released into the bloodstream for treatment of diseases requiring replacement of these molecules in the body.


TSX:SVA - Post by User

Comment by Redbaron2211on Jan 14, 2021 6:24pm
200 Views
Post# 32302718

RE:RE:RE:THANK YOU SERNOVA

RE:RE:RE:THANK YOU SERNOVARixpix good for you taking some profit, nothing wrong with that however I don't think anyone really cares.  Many have taken profit look at the volume over the last month.  Those shares are going into new hands that see the fundamental and technical set up.  When we ran on FDA news in 2018 it topped out quick and wasn't on especially high volume not to mention fundamentally we were years away from any results this is a different dimension w/ risk/reward.  

Selling the day before a potentially disruptive NR makes sense if you don't believe it will affect the SP in a positive way in which case selling at market makes sense as you will want to take the profit while you still can.  

Anyways best of luck looking forward to seeing the data.  


<< Previous
Bullboard Posts
Next >>